publication venue for
- Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models.. 215. 2025
- Phosphodiesterases S-sulfhydration contributes to human skeletal muscle function.. 177. 2022
- The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.. 113. 2016
- Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.. 105. 2016
- Extensive characterization of the human DDAH1 transgenic mice.. 60. 2009
- Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study.. 32. 1995
- Targeting hypoxia inducible factor-1 alpha in rheumatoid arthritis: Rationale, opportunities and challenges. 2024
- Drugs targeting SIRT1, a new generation of therapeutics for osteoporosis and other bone related disorders? 2019
- Sphingolipids as therapeutics. 2003
- Exploring the pharmacological versatility of ficus carica: Modulating classical immunometabolism and beyond. 2023
- Antibiotic use and the risk of breast cancer: A systematic review and dose-response meta-analysis. 2020
- Type 1 diabetes and T regulatory cells. 2015
- Prebiotics and probiotics; modifying and mining the microbiota. 2010
- The impairment of preconditioning-mediated cardioprotection in pathological conditions. 2009